Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ANGIO-FLO CONTIN-ARTERIAL FLUSH DEV.

K-Number: K832058 · 1983-09-12

ApplicantParke-Davis Co.
Decision Date1983-09-12
Product CodeKRA
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

ANGIO-FLO CONTIN-ARTERIAL FLUSH DEV. is the device name listed in this FDA 510(k) record. The listed applicant is Parke-Davis Co.. It received FDA 510(k) clearance on 1983-09-12 under 510(k) number K832058. The device is classified under product code KRA. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ANGIO-FLO CONTIN-ARTERIAL FLUSH DEV.?

ANGIO-FLO CONTIN-ARTERIAL FLUSH DEV. is a medical device that received FDA 510(k) clearance on 1983-09-12. The listed applicant is Parke-Davis Co.. The 510(k) number is K832058.

When did ANGIO-FLO CONTIN-ARTERIAL FLUSH DEV. receive FDA 510(k) clearance?

ANGIO-FLO CONTIN-ARTERIAL FLUSH DEV. received FDA 510(k) clearance on 1983-09-12, under 510(k) number K832058.

Who is the listed applicant for ANGIO-FLO CONTIN-ARTERIAL FLUSH DEV.?

The FDA 510(k) record lists Parke-Davis Co. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ANGIO-FLO CONTIN-ARTERIAL FLUSH DEV.?

The FDA product code for ANGIO-FLO CONTIN-ARTERIAL FLUSH DEV. is KRA.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Parke-Davis Co. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K861725INTRACATH INTRAVENOUS CATHETER PLACEMENT UNITK862119DESERET FLO-THRU INJECTATE TEMPERATURE SENSORK855120ATI DISPOSABLE BIOLOGICAL TEST PACKK860570ANGIO-FLO CONTINUOUS ARTERIAL CATH FLUSH DEVICEK860290VIAPIC CENTRAL LINE CATHETERK852192DISPOSABLE STEAM BIOLOGICAL TEST PACK

View all 47 devices →

Related Devices (Code: KRA)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K253509TriSalus TriNav Advance Infusion SystemTrisalus Life SciencesK254051Extroducer Infusion Catheter SystemSmartWise Sweden ABK261610Verge™ MicrocatheterInstylla, Inc.K260771TruSelect™ 2.6 MicrocatheterBoston Scientific CorporationK250794InVera Infusion DeviceInvera MedicalK243534Micro CatheterSuzhou Zenith Vascular SciTech Limited

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑